专利检索 ap:("Zealand Pharma A/S") AND inv:"PEDERSEN, Henrik Duelund" 第 1 页

1.

发明授权
GLUCAGON-GLP1 DUAL AGONISTS FOR USE IN THE TREATMENT OF CARDIAC CONDITIONS 有权
标题翻译：胰高血糖素-GLP-1双激动剂心脏病的治疗

公开(公告)号：EP2525809B1

公开(公告)日：2016-08-03

申请号：EP11704174.9

申请日：2011-01-20

申请人： Zealand Pharma A/S

发明人： PETERSEN, Jørgen Søberg , KJOELBYE, Anne Louise , SKOVGAARD, Marie , PEDERSEN, Henrik Duelund , AXELSEN, Lene , RIBER, Ditte , MEIER, Eddi , HANSEN, Rie Schultz , FOSGERAU, Keld , LARSEN, Bjarne Due

IPC分类号： A61K38/26 , A61P9/04

CPC分类号： C07K14/605 , A61K38/26 , C07K14/4705

2.

发明公开
TREATMENT OF CARDIAC CONDITIONS 有权
标题翻译：胰高血糖素-GLP-1双激动剂心脏病的治疗

公开(公告)号：EP2525809A1

公开(公告)日：2012-11-28

申请号：EP11704174.9

申请日：2011-01-20

申请人： Zealand Pharma A/S

发明人： PETERSEN, Jørgen Søberg , KJOELBYE, Anne Louise , SKOVGAARD, Marie , PEDERSEN, Henrik Duelund , AXELSEN, Lene , RIBER, Ditte , MEIER, Eddi , HANSEN, Rie Schultz , FOSGERAU, Keld , LARSEN, Bjarne Due

IPC分类号： A61K38/26 , A61P9/04

CPC分类号： C07K14/605 , A61K38/26 , C07K14/4705

摘要： The invention relates to the treatment of cardiac dysfunction. In particular, certain compounds, believed to be glucagon-GLP-1 dual agonist compounds, exert a positive inotropic effect while preserving the energy balance of the heart, and so may be superior to known inotropic agents such as dobutamine, norepinephrine and glucagon.